Who are NewAmsterdam Pharma Co N.V.'s main suppliers?

NewAmsterdam Pharma Co N.V. (NAMSW) key suppliers include: Merck & Co., Inc., Merck & Co., Inc., NewAmsterdam Pharma Company N.V., NewAmsterdam Pharma Company N.V.. View the full supplier network at chainsifter.com/chain/NAMSW.

Who are NewAmsterdam Pharma Co N.V.'s major customers?

NewAmsterdam Pharma Co N.V. (NAMSW) key customers include: Merck & Co., Inc., Merck & Co., Inc., NewAmsterdam Pharma Company N.V., NewAmsterdam Pharma Company N.V.. View the full customer network at chainsifter.com/chain/NAMSW.

What sector is NewAmsterdam Pharma Co N.V. in?

NewAmsterdam Pharma Co N.V. (NAMSW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NewAmsterdam Pharma Co N.V. Supplier List (NAMSW): 4 Verified Suppliers

4Suppliers

4Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

NewAmsterdam Pharma Co N.V. (NAMSW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships

1Distinct source URLs

2High confidence

0.756Average confidence

2026-09-22Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

NewAmsterdam Pharma Co N.V. Suppliers

Ticker	Name	Confidence	Evidence
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from NAMSW graph: ctions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit m…
MRK	Merck & Co., Inc.	72%	ctions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The IRA delayed the implem…
NAMS	NewAmsterdam Pharma Company N.V.	72%	ctions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The IRA delayed the implem…
NAMS	NewAmsterdam Pharma Company N.V.	72%	Reciprocal relationship from NAMS graph: Reciprocal relationship from NAMSW graph: ctions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit …

NewAmsterdam Pharma Co N.V. Customers

Ticker	Name	Confidence	Evidence
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from NAMSW graph: Reciprocal relationship from MRK graph: Reciprocal relationship from NAMSW graph: since been reinstated and, unless C…
MRK	Merck & Co., Inc.	72%	since been reinstated and, unless Congress and/or the Executive Branch take additional action, will begin to increase gradually starting in April 2030, reaching 4% in April 2031, until sequestration …
NAMS	NewAmsterdam Pharma Company N.V.	72%	Reciprocal relationship from NAMS graph: Reciprocal relationship from NAMSW graph: Reciprocal relationship from NAMS graph: Reciprocal relationship from NAMSW graph: since been reinstated and, unless…
NAMS	NewAmsterdam Pharma Company N.V.	72%	since been reinstated and, unless Congress and/or the Executive Branch take additional action, will begin to increase gradually starting in April 2030, reaching 4% in April 2031, until sequestration …

NewAmsterdam Pharma Co N.V. Debt Obligations

Instrument	Description	Confidence	Evidence
NAMSW-DEBT-11164	Warrants outstanding: 1638000	90%	xbrl warrant detail from xbrl 2025-12-31.
NAMSW-DEBT-11165	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.

NewAmsterdam Pharma Co N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NewAmsterdam Pharma Co N.V..

NewAmsterdam Pharma Co N.V. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for NewAmsterdam Pharma Co N.V..

NewAmsterdam Pharma Co N.V. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
NAMS	NewAmsterdam Pharma Company N.V.	100.00	1	['customer', 'supplier']
MRK	Merck & Co., Inc.	100.00	1	['customer', 'supplier']
DKS	DICK'S Sporting Goods, Inc.	50.00	2
IMMP	Immutep Limited	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
DYN	Dyne Therapeutics, Inc.	50.00	2
ADAG	Adagene Inc.	50.00	2
PSNL	Personalis, Inc.	50.00	2
ORANY	ORANGE	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
SLS	SELLAS Life Sciences Group, Inc.	50.00	2
EVFM	Evofem Biosciences, Inc.	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
EDSA	Edesa Biotech, Inc.	50.00	2
ELAN	Elanco Animal Health Incorporated	50.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	50.00	2
ENZN	Viskase Companies, Inc.	50.00	2
AVIR	Atea Pharmaceuticals, Inc.	50.00	2

NewAmsterdam Pharma Co N.V. Supply Chain